Učitavanje...

Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Transl Med
Glavni autori: Shishido, Stephanie N., Carlsson, Anders, Nieva, Jorge, Bethel, Kelly, Hicks, James B., Bazhenova, Lyudmila, Kuhn, Peter
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714097/
https://ncbi.nlm.nih.gov/pubmed/31462312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2035-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!